Математическое моделирование динамики межклеточных взаимодействий на примере противоракового иммунного ответа
Диссертация
В рамках данного проекта выполнены следующие задачи. Прежде всего, построена кинетическая модель иммунной реакции на небольшую популяцию опухолевых клеток с учетом ИЛ-2. Исследована динамика опухолевой популяции в различных условиях иммунного ответа. Показана важная роль презентации антигенов на поверхности антиген представляющих клеток для формирования эффективной иммунной реакции на слабо… Читать ещё >
Список литературы
- J.A. Adam, and N. Bellomo, A survey of Models for Tumor-Immune System Dynamics, Birkhauser, Boston, MA, 1996.
- B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, and J.D. Watson, Molecular biology of the cell (3rd edition), New York: Garland Publishing Inc., 1408 pp., 1994
- A.R.A. Anderson and M.A.J. Chaplain // Bulletin of mathematical biology. 1998. 60. P. 857−900
- J.C. Arciero, D.E. Kirschner, and T.L. Jackson. A mathematical model of tumor-immune evasion and siRNA treatment // Disc. Cont. Dyn. Syst.-B 4(1) (2004), P. 39—58.
- H.J. Bakker and H.-K. Nienhuys. Delocalization of protons in liquid water // Science, 297 (2002), P. 587−590.
- G.W. Barendsen Dose fractionation, dose rate and iso-effect relationships for normal tissue responses // Int. J. Radiat. Oncol. Biol. Phys. 1982. 8. P. 1981−1997.
- A.C. Buzaid and M. Atkins. Practical guidelines for the management of biochemotherapy-related toxicity in melanoma // Clin. Cancer Res, 7 (2001), P. 2611—2619.
- A.C. Buzaid. Strategies for combining chemotherapy and biotherapy in melanoma // Cancer Control, 7(2) (2000), P. 185—197.
- H.M. Byrne, I.M.M. van Leeuwen, M.R. Owen, T. Alarcon, and P.K. Maini. Multi-scale modelling of solid tumour growth // Selected Topics in Cancer Modeling. Chapter 17, Springer Science+Business Media (2008) P. 249−473
- A. Casrouge, E. Beaudoing, S. Dalle, C. Pannetier, J. Kanellopoulos, and P. Kourilsky. Size estimate of the ab TCR repertoire of naive mouse splenocytes // The Journal of Immunology, 164 (2000), 5782−5787.
- D.L. Chao, M.P. Davenport, S. Forrest, and A.S. Perelson. A stochastic model of cytotoxic T cell responses // Journal of Theoretical Biology, 228 (2004), 227—240.
- M. Chaplain and A. Matzavinos. Mathematical modeling of spatio-temporal phenomena in tumor immunology // Lect. Notes Math. 1872 (2006), 131 -183
- M.A.J. Chaplain. Mathematical models in cancer research // The Cancer Handbook. Chapter 60, Nature publishing group. (2003) P. 937—951.
- M.A.J. Chaplain, S.M. Giles, B.D. Sleeman, R.J. Jarvis, A mathematical analysis of a model for tumour angiogenesis //J. Math. Biol. 33, 744−770 (1995)
- W.E. Cheong, S.A. Prahl, and A.J. Welch, A Review of the optical properties of biological tissues // IEEE J. Quantum Electron, 26 (1990) P. 2166−2185.
- S.F. Cleary, L.M. Liu, and R.E. Merchant. Lymphocyte proliferation induced by radio-frequency electromagnetic radiation under isothermal conditions // Bioelectromagnetics, 11 (1990), P. 4756.
- I.H. Coggin, A.L. Barsoum, J.W. Rohrer, Tumors express both unique TSTA and crossprotective 44 kDa oncofetal antigen. Immunology Today. 1998. 19. P. 405−408
- S.B. Curtis, Lethal and potentially lethal lesions induced by radiation. A unified repair model // published erratum appears in Radiation Research, 119, 584, 1989]. Radiation Research, 106 (1986), P. 252−270.
- B.J. Dale, R.G. Dale. Mathematical models of tumour and normal tissue response // Acta Oncologia. V. 38. № 7 (1999), P. 883−893.
- R.G. Dale. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy// Br. J. Radiol. 58 (1985), P. 515−28.
- R.J. De Boer, P. Hogeweg, F.J. Dullens, R.A. De Weger and W. Den Otter. Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model // J. Immunol. 134(4) (1985), P. 2748—2758.
- S. Demaria, N. Bhardwaj, W.H. McBride, S.C. Formenti. Combining radiotherapy and immunotherapy: a revived partnership // Int. J. Radiat. Oncol. Biol. Phys. V. 63. № 3 (2005), P. 655−666
- C. DeLizi and A. Rescingo, Immune surveillance and neoplasia — I: a minimal mathematical model. Bull. Math. Biol. 1977. 39. P. 201−221
- L.G. de Pillis and A.E. Radunskaya. Immune response to tumor invasion // Computational Fluid and Solid Mechanics / K. Bathe, eds., Vol. 2 Cambridge: MIT Press, MA (2003), P. 1661—1668.
- L.G. de Pillis, W. Gu and A.E. Radunskaya. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations // J. of Theoretical Biology. 238(4) (2006), P. 841−862.
- L.G. de Pillis and A. Radunskaya. A mathematical tumor model with immune resistance and drug therapy: an optimal control approach // Journal of Theoretical Medicine, 3 (2001), P. 79−100.
- L.G. de Pillis, W. Gu, K.R. Fister, T. Head, K. Maples, T. Neal, A. Murugan and K. Yoshida. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls // Mathematical Biosciences, 209 (2007), P. 292−315.
- A. Diefenbach, E.R. Jensen, A.M. Jamieson and D. Raulet. Rael and H60 ligands of the NKG2D receptor stimulate tumor immunity//Nature, 413 (2001), P. 165—171.
- T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng. Photodynamic therapy// J. Natl. Cancer Inst., 90 (12) (1998), P. 889−905
- C.H. Durney, M.F. Iskander, H. Massoundi, and C.C. Johnson. An empirical formuls for broadband SAR calculation of prolate spheroidal models of humans and animals // IEEE Trans. Microwave theory techn., MTT-27(8) (1979), P. 758—763.
- A. Ergun, K. Camphausen, L.M. Wein, Optimal scheduling of radiotherapy and angiogenic inhibitors // Bulletin of Mathematical Biology, 65 (2003), P. 407−424
- J. Folkman, Tumor angiogenesis: therapeutic implications //N. Engl. J. Med. 285 (1971), P. 1182−1186.
- J.F. Fowler and B.E. Stern Dose-rate effects: some theoretical and practical considerations // Br. J. Radiol. 1960. 33. P. 389−95.
- R. Garay and R. Lcfcvcr, A kinetic approach to the immunology of cancer: stationary states properties of effector-target cell reactions // J. Theor. Biol., 73 (1978), P. 417—438.
- S. Garbelli, S. Mantovani, B. Palermo, and C. Giachino, Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity// Pigment Cell Res. 18 (2005), P. 234—242.
- M. Garcia-Barros, F. Paris, C. Cordon-Cardo, D. Lyden, S. Rafii, A. Haimovitz-Friedman, Z. Fuks, R Kolesnick. Tumor response to radiotherapy regulated by endothelial cell apoptosis // Scicnce. 300 (2003), P. 1155 1159
- S.N. Gardner, A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and nonspecific drugs // Cancer Res., 60 (2000), P. 1417—1425.
- P. Hahnfeldt, D. Panigraphy, J. Folkman, L. Hlatky Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy // Cancer Res. 59 (1999), P. 4770−4775.
- I. Нага, H. Hotta, N. Sato, H. Eto, S. Arakava, and S. Kamidono, Rejection of mouse renal cell carcinoma elicited by local secretion of interleukin-2 // J. Cancer Res. 87 (1996), P. 724—729.
- S. Heegaard, M. Spang-Thomsen, and J.U. Prause, Establishment and characterization of human uveal malignant melanoma xenografts in nude mice // Melanoma Research, 13(3) (2003), P. 247 251.
- Z. Hu, Y. Sun, and G. Alan, Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model // Proc. Natl. Acad. USA, 96 (1999), P. 8161—8166.
- M.J. Jackson, A. McArdle, and F. McArdle, Antioxidant micronutrients and gene expression // Proceedings of the Nutrition Society, 57 (1998), 301−305.
- T.L. Jackson, Vascular tumor growth and treatment: consequences of polyclonality, competition and dynamic vascular support // J. Math. Biol. 44 (2002), P. 201−226.
- G. Jori, M. Beltramini, E. Reddi, B. Salvato, A. Pagnan, L. Ziron, L. Tomio, and T. Tsanov. Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. // Cancer Lett. 24(1984), P. 291−297
- J. Kiefer, A repair fixation model // Quantitative Mathematical Models in Radiation Biology. / edited by J. Kiefer. Berlin and New York: Springer-Verlag. (1988), P. 171 180.
- J.V. Kim, J.B. Latouche, I. Riviere, M. Sadelain, The ABCs of artificial antigen presentation. Nat Biotechnol. 2004. 22. P. 403−410
- D. Kirschner and J, C. Panetta, Modeling immunotherapy of the tumor-immune interaction // J. of Mathematical Biology, 37 (1998), P. 235—252.
- R. Konig and W. Zhou, Signal transduction in T helper cells: CD4 coreceptors exert complex regulatory effects on T cell activation and function // Curr. Issues Mol. Biol. 6(1) (2004)
- M. Korbelik and G.J. Dougherty. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors // Cancer research, 59 (1999) P. 1941—1946
- V.A. Kuznetsov, I.A. Makalkin, M.A. Taylor and A.S. Perelson, Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis // Bull. Math. Biol. 56(2) (1994), P. 295—321.
- K. Lang, F. Entschladen. C. Weidt, K.S. Zaenkcr. Tumor immune escape mechanisms: impact of the neuroendocrine system// Cancer Immunol Immunother, 55 (2006), P. 749−760.
- D.E. Lea. Actions of Radiations on Living Cells. London. Cambridge University Press.- (1946).
- J.Li, K. Guo, V.W. Koh, J.P. Tang, B.Q. Gan, H. Shi, H.X. Li and Q. Zcng, Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases // Clin. Cancer Res, 11(6) (2005), P. 2195—2204.
- Y. Liu, Y. Ng, and K.O. Lillehei, Cell mediated immunotherapy: a new approach to the treatment of malignant glioma // Cancer Control, 10(2) (2003), P. 138—147.
- C. Lobo, M.A. Ruiz-Bellido, J.C. Aledo, J. Marquez, I. Nunez de Castro, and F.J. Alonso, Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells // Biochem. J., 348 (2000), P. 257—261.
- T.J. Loo, G.E. Housholder, A.H. Gerulath, P.H. Saunders, D. Farquhar, Mechanism of action and pharmacology studies with DTIC (NSC-45 388) // Canccr Treatment Reports, 60 (1976) P. 149 152.
- J. Lu, R. L. Giuntoli, II, R. Omiya, H. Kobayashi, R. Kennedy, and E. Celis, Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes // Clinical Cancer Research, 8 (2002), P. 3877—3884.
- P. Macklin, S. McDougall, A.R.A. Anderson, M.A.J Chaplain, V. Cristini, and J. Lowengrub, Multiscale modelling and nonlinear simulation of vascular tumour growth J Math Biol 58(4−5) (2009), P. 765−798
- D.G. Malleta and L.G. dc Pillis, A cellular automata model of tumor-immune system interactions // J. of Theor. Biol., 239 (2006), P. 334 350.
- A. Matzavinos and M.A.J. Chaplain, Travelling-wave analysis of a model of the immune response to cancer // С R Biol. 327(11) (2004), P. 995−1008.
- A. Matzavinos, M.A.J. Chaplain, and Y.A. Kuznetsov, Mathematical modeling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour // Mathematical Medicine and Biology 21 (2004), P. 1−34
- S.R. McDougall, A.R.A. Anderson, M.A.J. Chaplain, J.A. Sherratt. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies. Bull. Math. Biol. 64, (2002) P. 673−702
- S.R. McDougall, A.R.A. Anderson, and M.A.J. Chaplain, Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. Bull. Math. Biol., 241, (2006) P. 564−589
- S.J. Merril, Foundations of the use of an enzyme-kinetic analogy in cell-mediated cytotoxicity // Math. Biosci., 62 (1982), P. 219—235.
- National Cancer Institute, 2005. National cancer institute clinical trials web site. Available at http://www.nci.nih.gov/clinicaltrials accessed December 2005.
- L. Norton, A Gompertzian model of human breast growth // Cancer. Res., 48 (1988), P. 7067— 7071.
- K.J. O’Byrne, A.G. Dalgleish, M.J. Browning, W.P. Steward and A.L. Harris, The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease // Eur.J.Cancer. 36, (2000) P. 151−169.
- A. Ochab-Marcinek, and E. Gudowska-Nowak, Population growth and control in stochastic models of cancer development // Physica A, 343 (2004), P. 557−572.
- J.E. Ohm and D.P. Carbone. VEGF as a Mediator of Tumor-Associated Immunodeficiency // Immunologic Research. 2001. 23−2/3. P. 263−272
- M.R. Owen and J, A. Sherratt. Pattern formation and spatiotemporal irregularity in a model for macrophage-tumour interactions // J. Theor. Biol. 189 (1997), P. 63−80.
- M.R. Owen and J.A. Sherratt, Mathematical modelling of macrophage dynamics in tumours // Math. Models Meth. Appl. Sci. 9 (1999), P. 513−539
- Z. Qu, G.L. Griffiths, W.A. Wegener, C.H. Chang, S.V. Govindan, I.D. Horak, H.J. Hansen and D.M. Goldenberg, Development of humanized antibodies as cancer therapeutics // Methods, 36(1) (2005), P. 84—95.
- L. Raffaghello, I. Prigione, P. Bocca, F. Morandi, M. Camoriano, C. Gambini, et al., Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications // Oncogene, 24 (2005), P. 4634—4644.
- K. Reisenberger, C. Egarter, S. Vogl, B. Sternberger, H. Kiss, P. Husslein, The transfer of interleukin-8 across the human placenta perfused in vitro // Obstet Gynecol. 87 (1996), P. 613— 616.
- R.J. Reiter, R.C. Carneiro, and C.S. Oh, Melatonin in relation to cellular antioxidative defense mechanisms // Horm. Metab. Res., 29(8) (1997), P. 363−372.
- RESAN Scientific Research Enterprise, 2003. Scientific research enterprise web site. Available at http://www.anticancer.net/resan/basis.html#interleukins
- J.W. Rooney, Y.L. Sun, L.H. Glimcher, and T. Hoey, Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation // Mol. Cell. Biol., 15 (1995), P. 6299−6310.
- E. Rosenbaum and I. Rosenbaum. Everyone’s guide to cancer supportive care: a comprehensive handbook for patients and their families. Andrews McMeel Publishing, 2005.
- S.A. Rosenberg and M. T. Lotze. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes // Annual Review of Immunology, 4 (1986), P. 681—709.
- R.K. Sachs, P. Hahnfeld, D.J. Brenner, The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair // Int. J. Radiat. Biol. V. 72. № 4 (1997) P. 351−374
- V. Schirrmacher, V. Umansky, M. binder, S. Miierkoster, M. Rocha, Models for immunotherapy and Cancer Vaccines // The Cancer Handbook, Chapter 68. Nature publishing group, (2003), P. 1055—1068.
- D.J. Sehwartzentruber, In Vitro predictors of clinical response in patients receiving interleukin-2-based immunotherapy// Current opinion in oncology, 5 (1993), P. 1055—1058.
- Shenzhen Neptunus Interlong Bio-Tech Holdings Co., Intrelong web site, 2005. Available at http://www.interlong.com/en/Products.asp.
- J. A. Sherratt, J.D. Murray, Models of epidermal wound healing, Proc. R. Soc. Lond. В 241 (1990) P. 29−36
- J. Sherrat, and M. Nowak, Oncogenes, anti-oncogenes and the immune response to cancer: a mathematical model// Proc. R. Soc. London В 248 (1992), P. 261—271.
- O. Sotolongo-Grau, D. Rodriguez-Perez, J.A. Santos-Miranda, O. Sotolongo-Costa, J.C. Antoranz. Immune system-tumour efficiency ratio as a new oncological index for radiotherapy treatment optimization // Math. Med. Biol. 26(4) (2009), P. 297−307
- C.L.Stokes, M.A. Rupnick, S.K. Williams, D.A. Lauffenburger. Chemotaxis of human microvessel endothelial cells in response to acidic fibroblast growth factor // Lab. Invest. 63, (1990), P. 657−668.
- M. Sznol and T. Davis. Antibodies and recombinant cytokines // The Cancer Handbook, Chapter 87. Nature publishing group, (2003), P. 1371—1379.
- H.D. Thames. An 'incomplete-repair' model for survival after fractionated and continuous irradiations // Int. J.Radiat. Oncol. Biol. Phys. 1985. 47. P. 319−39.
- H.D. Thames, J.L. Hendry. Fractionation in Radiotherapy // London. Taylor and Francis, (1987).
- C.A. Tobias, E.A. Blakely, F.Q.H. Ngo, T.C.Y. Yang. The repair-misrepair model of cell survival // Radiation Biology in Cancer Research / edited by R.E. Meyn and H.R. Withers. New York: Raven Press. (1980), P. 195 229.
- S.L. Tucker and J.M.G. Taylor. Improved models of tumor cure // Int. J. Radiat. Oncol. Biol. Phys. 1996. 70. P. 539−553.
- M. Valko, D. Leibfritz, J. Moncola, M.T.D. Cronin, M. Mazur, and J. Telser. Free radicals and antioxidants in normal physiological functions and human disease // Review is available online at www.sciensdirect.com
- H.H. van Ravenswaay Claasen, P.M. Kluin, G.J. Fleuren. Tumor infiltrating cells in human cancer. On the possible role of CD 16+ macrophages in antitumor cytotoxicity // Lab Invest, 67 (1992), P. 166−174
- H.P. Vladar and J. A. Gonzalez, Dynamic response of cancer under the influence of immunological activity and therapy, J. Theor. Biol. 227 (2004), P. 335—348.
- V.L. Voeikov. Biological significance of active oxygen-dependent processes in aqueous systems // Water and the cell (Dordrecht: Springer) / G.H. Pollack, I.L. Cameron and D.N. Wheatley (Ed.)2006), P. 285−298
- A.D. Wells, S.K. Rai, S. Salvato, H. Band, and M. Malkovsky, HSP-72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation // International Immunology, 10(5) (1998), P. 609−617.
- C.J. Wheeler, D. Asha, L. Genatao, J.S. Yu and K.L. Black, Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination // Clin. Cancer Res, 10 (2005), P. 5316—5326.
- D. Wodarz and A.R. Thomsen, Does programmed CTL proliferation optimize virus control? // Trends Immunol. 26 (2005), P. 305−310
- И.М. Белоусова, Н. Г. Миронова, М. С. Юрьев. Математическая модель фотодинамического действия фуллерена на биологические ткани // Оптика и спектроскопия, 98(3), (2005), С. 390−398
- О.В. Глушкова, Е. Г. Новоселова, О. А. Синотова, Е. Е. Фесенко, Иммунокорректирующее действие низкоинтенсивного сверхвысокочастотного излучения при канцерогенезе у мышей//Биофизика, 48(2) (2003), С. 281−288.
- М.Л. Гельфонд. Фотодинамическая терапия в онкологии // Практическая онкология, 8(4)2007) С. 204—210.
- А. А. Красновский Синглетный молекулярный кислород и первичные механизмы фотодинамического действия оптического излучения // Итоги современной науки и техники. Современные проблемы лазерной физики, (3) М.: ВИНИТИ, (1990), С. 63−136
- Е.Г. Новоселова, Д. А. Черенков, О. В. Глушкова, Т. В. Новоселова, В. М. Чудновский, В. И. Юсупов, Е. Е. Фесенко. Действие низкоинтенсивного лазерного излучения (632,8 нм) на изолированные клетки иммунной системы мышей //Биофизика, 51(3), (2006), С. 509−518
- И. Ройт, Дж. Бростофф, Д. Мейл. Иммунология М.: Мир, (2001), 592 с.
- Ю.М. Романовский, Н. В. Степанова, Д. С. Чернавский. Математическая биофизика. —М.: Наука, 1984.
- Е, Б. Черняева, Н. В. Степанова, Л. Л. Литинская. Механизмы взаимодействия фотосенсибилизаторов с клетками // Итоги науки и техники. Современные проблемы лазерной физики, (3) М.: ВИНИТИ, (1990), С. 136−224
- B.C. Шапот. О проявлениях и механизмах системного действия опухоли на организм.//Патофизиол. и эксперим. терапия, № 3, (1974), С. 3